Abstract
Objectives: The valve-in-valve (VIV) technique is an emerging therapeutic option for patients with failure of previously implanted xenografts. We describe a balloon-expandable transthoracic transapical mitral VIV implantation in an emergency setting in a 69-year-old woman with dysfunction of the mitral bioprosthesis. Methods: Left ventricular apical access was applied. After balloon valvuloplasty, a 26-mm Edwards-Sapien transcatheter valve (Edwards Lifesciences LLC, Irvine, CA, USA) was deployed within the mitral xenograft, using rapid ventricular pacing. Results: The transcatheter valve functioned properly postoperatively and three-dimensional echocardiography carried out 1 month later showed a well-functioning VIV prosthesis and no mitral stenosis (mitral valve area 3 cm 2, mean gradient 3 mmHg). Conclusions: In this patient, VIV implantation was found to be a safe alternative to an emergent valve replacement. It might represent a suitable option to conventional procedures even among lower risk patients. ©2011, Wiley Periodicals, Inc.
Cite
CITATION STYLE
Van Garsse, L. A. F. M., Gelsomino, S., Van Ommen, V., LucÇ, F., & Maessen, J. (2011). Emergency transthoracic transapical mitral valve-in-valve implantation. Journal of Interventional Cardiology, 24(5), 474–476. https://doi.org/10.1111/j.1540-8183.2011.00637.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.